<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the case of a 26-year-old woman who developed <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo> in her left leg in 2002, followed by <z:hpo ids='HP_0001945'>fever</z:hpo>, asthenia and <z:hpo ids='HP_0002315'>headache</z:hpo> in 2004 </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003493'>Antinuclear antibodies</z:hpo>, antimitochondrial antibodies, anti-liver kidney microsome, anti-Smith, antiphospholipid (aPL) and antineutrophil cytoplasmic antibodies, as well as <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>- <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity were positive </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002725'>Systemic lupus erythematosus</z:hpo> (SLE) with aPL syndrome was diagnosed and the patient was treated with <z:chebi fb="2" ids="2948">azathioprine</z:chebi> and <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Symptoms persisted and <z:e sem="disease" ids="C0033774" disease_type="Disease or Syndrome" abbrv="">itching</z:e> arose in the following months </plain></SENT>
<SENT sid="4" pm="."><plain>The patient was admitted to our department in January 2005 for <z:hpo ids='HP_0000952'>jaundice</z:hpo> and <z:hpo ids='HP_0000988'>skin rash</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Elevated levels of <z:hpo ids='HP_0011009'>acute</z:hpo> phase proteins and <z:hpo ids='HP_0001396'>cholestasis</z:hpo> and <z:mp ids='MP_0001654'>liver necrosis</z:mp> indexes were present </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0003493'>Antinuclear antibodies</z:hpo>, aPL and antimitochondrial antibodies (M5) antibodies were positive </plain></SENT>
<SENT sid="7" pm="."><plain>Liver histology showed minimal focal hepatocyte <z:mp ids='MP_0001651'>necrosis</z:mp>, <z:mp ids='MP_0005415'>intrahepatic biliary stasis</z:mp> and intralobular inflammatory cell infiltrate </plain></SENT>
<SENT sid="8" pm="."><plain>The absence of clinical signs that are characteristic of SLE as well as the failure to confirm antiSmith antibody positivity led us to rule out a diagnosis of SLE </plain></SENT>
<SENT sid="9" pm="."><plain>On the basis of clinical, immunological and histological data, autoimmune intrahepatic cholangiopathy associated with primary aPL syndrome was diagnosed </plain></SENT>
<SENT sid="10" pm="."><plain>The patient was treated with intravenous <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> followed by oral <z:chebi fb="0" ids="8382">prednisone</z:chebi>, <z:chebi fb="8" ids="10033">warfarin</z:chebi> and <z:chebi fb="1" ids="9907">ursodeoxycholic acid</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain><z:mp ids='MP_0001654'>Liver necrosis</z:mp> and <z:hpo ids='HP_0001396'>cholestasis</z:hpo> indexes rapidly improved within 1 month and progressively reached the <z:mpath ids='MPATH_458'>normal</z:mpath> range </plain></SENT>
<SENT sid="12" pm="."><plain>To our knowledge, this is the first description of a patient with an association of intrahepatic cholangiopathy and aPL, thus suggesting that <z:e sem="disease" ids="C0400936" disease_type="Disease or Syndrome" abbrv="">autoimmune liver disease</z:e> might associate with aPL syndrome </plain></SENT>
</text></document>